ARROWHEAD PHARMACEUTICALS, INC.

ARROWHEAD PHARMACEUTICALS, INC. (ticker: ARWR) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of ARWR's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. ARWR reported $337.77M in revenue and -$101.92M for the period ending 2026-03-31, with operating cash flow of $97.92M. Cash and equivalents stood at $188.52M (up 1.5% year-over-year). Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.